Optiver Holding
XBIT icon

Optiver Holding’s XBiotech XBIT Stock Holding History

Optiver Holding’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19 Hold
8
– – ﹤0.01% 2270
2025
Q4 		$19 Hold
8
– – ﹤0.01% 2415
2025
Q3 		$21 Buy
+8
New +$24 ﹤0.01% 2645

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Optiver Holding's XBIT Position: Q1 2026 in Review

Optiver Holding held its XBiotech (XBIT) position steady in Q1 2026 at 8 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Optiver Holding first reported a position in XBIT in Q3 2025 and has held it in 3 quarters since. The position peaked at $21 in Q3 2025. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Optiver Holding held 8 shares of XBiotech worth $19 as of Q1 2026.
  • Optiver Holding left its XBiotech share count unchanged in Q1 2026.
  • XBiotech made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2270 holding.
  • Optiver Holding first reported a position in XBiotech in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's XBiotech position peaked at $21 in Q3 2025.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.